S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
OTCMKTS:REPR

Repro-Med Systems - REPR Stock Forecast, Price & News

$3.26
-0.13 (-3.83%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.22
$3.44
50-Day Range
$2.17
$3.39
52-Week Range
$1.35
$4.26
Volume
11,531 shs
Average Volume
36,047 shs
Market Capitalization
$130.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
REPR stock logo

About Repro-Med Systems (OTCMKTS:REPR) Stock

Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

Receive REPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Repro-Med Systems and its competitors with MarketBeat's FREE daily newsletter.

REPR Stock News Headlines

REPRO MED SYSTEMS INC (NASDAQ: KRMD)
Repro Medsystems
Should I Avoid Repro Med Systems, Inc. (KRMD)?
Repro-Med Systems: Q2 Earnings Insights
See More Headlines
Receive REPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Repro-Med Systems and its competitors with MarketBeat's FREE daily newsletter.

REPR Company Calendar

Last Earnings
8/06/2019
Today
12/09/2022

Industry, Sector and Symbol

Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:REPR
Fax
N/A
Employees
75
Year Founded
N/A

Profitability

Net Income
$910,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$17.35 million
Cash Flow
$0.03 per share
Book Value
$0.23 per share

Miscellaneous

Free Float
N/A
Market Cap
$130.03 million
Optionable
Not Optionable
Beta
-0.40

Key Executives

  • Mr. Daniel S. Goldberger (Age 60)
    Exec. Chairman
  • Mr. Donald B. Pettigrew (Age 51)
    CEO, Pres & Chief Commercial Officer
  • Ms. Karen Fisher (Age 53)
    CFO, Treasurer & Corp. Sec.
  • Mr. Manuel A. Marques (Age 46)
    Chief Operating Officer
  • Mr. Steven Kamphausen
    Global VP of Sales & Marketing













REPR Stock - Frequently Asked Questions

How have REPR shares performed in 2022?

Repro-Med Systems' stock was trading at $3.00 at the beginning of the year. Since then, REPR shares have increased by 8.7% and is now trading at $3.26.
View the best growth stocks for 2022 here
.

How were Repro-Med Systems' earnings last quarter?

Repro-Med Systems, Inc. (OTCMKTS:REPR) issued its quarterly earnings data on Tuesday, August, 6th. The company reported $0.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by $0.02. The business had revenue of $5.35 million for the quarter. Repro-Med Systems had a net margin of 0.17% and a trailing twelve-month return on equity of 7.63%.

What other stocks do shareholders of Repro-Med Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Repro-Med Systems investors own include Globus Medical (GMED), KORU Medical Systems (KRMD), Allena Pharmaceuticals (ALNA), Aileron Therapeutics (ALRN), ERYTECH Pharma (ERYP), Palatin Technologies (PTN), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB),

What is Repro-Med Systems' stock symbol?

Repro-Med Systems trades on the OTCMKTS under the ticker symbol "REPR."

How do I buy shares of Repro-Med Systems?

Shares of REPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Repro-Med Systems' stock price today?

One share of REPR stock can currently be purchased for approximately $3.26.

How much money does Repro-Med Systems make?

Repro-Med Systems (OTCMKTS:REPR) has a market capitalization of $130.03 million and generates $17.35 million in revenue each year.

How can I contact Repro-Med Systems?

Repro-Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The official website for the company is www.rmsmedicalproducts.com. The company can be reached via phone at 845-469-2042 or via email at dsullivan@equityny.com.

This page (OTCMKTS:REPR) was last updated on 12/10/2022 by MarketBeat.com Staff